The combination of hypomethylating agents and histone deacetylase inhibitors produce marked synergy in preclinical models of T‐cell lymphoma

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 7-1048, Iss. 2, 2015-10 ,pp. : 215-226

John Wiley & Sons Inc

Access to resources Recommend Favorite

Entinostat, a novel histone deacetylase inhibitor is active in B‐cell lymphoma and enhances the anti‐tumour activity of rituximab and chemotherapy agents

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 169, Iss. 4, 2015-05 ,pp. : 506-519

John Wiley & Sons Inc

Access to resources Recommend Favorite

Combination therapy of conditionally replicating adenovirus and histone deacetylase inhibitors

By                    

International Journal of Molecular Medicine, Vol. 29, Iss. 2, 2012-01 ,pp. : 218-224

Spandidos Publications

Access to resources Recommend Favorite

Successful Treatment of Adult T‐cell Leukemia/Lymphoma with MACOP‐B, M‐FEPA and VEPP‐B Combination Chemotherapy

By  

THE JOURNAL OF DERMATOLOGY, Vol. 20, Iss. 10, 1993-10 ,pp. : 623-629

John Wiley & Sons Inc

Access to resources Recommend Favorite

T-cell lymphoma manifesting as a uvular mass

By Lai Wen-Sen  

British Journal of Rheumatology , Vol. 52, Iss. 4, 2013-04 ,pp. : 608-608

Oxford University Press

Access to resources Recommend Favorite